This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Montalban, J. Articles by Gil, A. Search for Related Content PubMed PubMed Citation Articles by Montalban, J. Articles by Gil, A.

Stroke, Vol 25, 2412-2415, Copyright © 1994 by American Heart Association

ARTICLES

Value of immunologic testing in stroke patients. A prospective multicenter study

J Montalban, J Rio, M Khamastha, A Davalos, M Codina, GT Swana, ME Calcagnotto, J Sumalla, S Mederer and A Gil
Servei de Neurologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.

BACKGROUND AND PURPOSE: The aims of this prospective and multicenter study were to determine the frequency of anticardiolipin and antinuclear antibodies in an unselected ischemic and hemorrhagic stroke population and to evaluate the clinical significance of these autoantibodies. METHODS: Over a 1-year period, we collected plasma from 481 consecutive patients with ischemic or hemorrhagic stroke attending four different hospitals. Blood (10 mL) was drawn from each subject into a citrated glass tube. Plasma was obtained immediately by centrifugation and was stored at -70 degrees C until use. Concentrations of IgM and IgG anticardiolipin antibodies were measured at room temperature in normal (not heat-treated) plasma by standardized enzyme-linked immunosorbent assay. All sera were treated by indirect immunofluorescence on mouse liver and kidney sections for antinuclear antibodies. RESULTS: A total of 481 patients (325 men, 156 women) 16 to 90 years in age (mean age, 61 years) were studied. Anticardiolipin antibodies were present in 5 of 481 (1.04%) patients. One patient was IgG positive and four patients were IgM positive. Of 481 patients, 35 (7.2%) were positive for antinuclear antibodies. Anti-DNA antibodies were not demonstrable in any patient. CONCLUSIONS: The frequency of anticardiolipin antibodies in a heterogeneous stroke population is possibly lower than reported. The routine screening of anticardiolipin and antinuclear antibodies in a stroke population is of questionable value.

This article has been cited by other articles:

				W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 69 - 76. [Abstract] [PDF]

				W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 203 - 210. [Abstract] [PDF]

				J Sastre-Garriga and X Montalban APS and the brain Lupus, December 1, 2003; 12(12): 877 - 882. [Abstract] [PDF]

				M-H Tsai, W-P Tsai, S-T Liao, and L-b Liou Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis Lupus, October 1, 2003; 12(10): 747 - 753. [Abstract] [PDF]

				S. Tuhrim, J. H. Rand, X. Wu, D. R. Horowitz, J. Weinberger, M. E. Goldman, and J. H. Godbold Antiphosphatidyl serine antibodies are independently associated with ischemic stroke Neurology, October 22, 1999; 53(7): 1523 - 1523. [Abstract] [Full Text] [PDF]

				S. Tuhrim, J. H. Rand, X.-X. Wu, J. Weinberger, D. R. Horowitz, M. E. Goldman, and J. H. Godbold Elevated Anticardiolipin Antibody Titer Is a Stroke Risk Factor in a Multiethnic Population Independent of Isotype or Degree of Positivity Stroke, August 1, 1999; 30(8): 1561 - 1565. [Abstract] [Full Text] [PDF]

				D. Tanne, D. A. Triplett, and S. R. Levine Antiphospholipid-Protein Antibodies and Ischemic Stroke : Not Just Cardiolipin Any More Stroke, September 1, 1998; 29(9): 1755 - 1758. [Full Text] [PDF]

				H. S Markus and H. Hambley Neurology and the blood: haematological abnormalities in ischaemic stroke J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 150 - 159. [Full Text] [PDF]

				R. Brey and A. Escalante Review : Neurological manifestations of antiphospholipid antibody syndrome Lupus, January 1, 1998; 7(2_suppl): S67 - S74. [Abstract] [PDF]

				B. Kristensen, J. Malm, B. Carlberg, B. Stegmayr, C. Backman, M. Fagerlund, and T. Olsson Epidemiology and Etiology of Ischemic Stroke in Young Adults Aged 18 to 44 Years in Northern Sweden Stroke, September 1, 1997; 28(9): 1702 - 1709. [Abstract] [Full Text]